Dr. Michael A. Danso
Claim this profileVirginia Oncology Associates
Expert in Breast Cancer
Studies Pancreatic Cancer
14 reported clinical trials
24 drugs studied
Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
2Pancreatic Cancer
Stage IV
Stage III
HER2 negative
Affiliated Hospitals
Clinical Trials Michael A. Danso is currently running
Abemaciclib + Elacestrant
for Brain Metastasis from Breast Cancer
This trial tests a combination of two drugs, elacestrant and abemaciclib, in patients with a specific type of breast cancer. It aims to find the best dose and see how well it works for those whose cancer has spread to the brain. The drugs work by blocking signals that help cancer cells grow and divide. Abemaciclib is a drug that has been approved for the treatment of certain advanced breast cancers.
Recruiting1 award Phase 1 & 212 criteria
Elacestrant Combinations
for Breast Cancer
This is a multicenter, Phase 1b/2 trial in participants with estrogen receptor positive/human epidermal growth factor receptor 2 negative (ER+/HER2-) advanced/metastatic breast cancer. The phase 1b part of the trial will determine the recommended Phase 2 dose (RP2D) of elacestrant when administered in combination with alpelisib, everolimus, palbociclib, capivasertib, and ribociclib. The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations.
Recruiting1 award Phase 1 & 2
More about Michael A. Danso
Clinical Trial Related3 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Michael A. Danso has experience with
- Trilaciclib
- Abemaciclib
- Placebo
- Exemestane
- Enobosarm
- Elacestrant
Breakdown of trials Michael A. Danso has run
Breast Cancer
Pancreatic Cancer
Cancer
Kennedy's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael A. Danso specialize in?
Michael A. Danso focuses on Breast Cancer and Pancreatic Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Michael A. Danso currently recruiting for clinical trials?
Yes, Michael A. Danso is currently recruiting for 3 clinical trials in Norfolk Virginia. If you're interested in participating, you should apply.
Are there any treatments that Michael A. Danso has studied deeply?
Yes, Michael A. Danso has studied treatments such as Trilaciclib, Abemaciclib, Placebo.
What is the best way to schedule an appointment with Michael A. Danso?
Apply for one of the trials that Michael A. Danso is conducting.
What is the office address of Michael A. Danso?
The office of Michael A. Danso is located at: Virginia Oncology Associates, Norfolk, Virginia 23502 United States. This is the address for their practice at the Virginia Oncology Associates.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.